Myositis is a common clinical syndrome in advanced stages of AIDS. Trachipleistophora hominis (phylum Microspora) has been detected in several cases of painful, immobilising myositis in AIDS patients. Enzyme linked immunosorbent assays (ELISAs) and Western blotting of protein profiles separated by SDS PAGE were used to determine whether this species could be detected and differentiated by serology. Sixteen microsporidia, including severa species known to infect man and species infecting fish, crustaceans and a mosquito, were used as antigen. Each species had a unique profile of SDS PAGE-separated proteins. In Western blots, mouse antiserum, raised to T. hominis and selected for its high ELISA specificity, bound to antigens ranging from less than 25 kDa to greater than 250 kDa with major bands at 39-44 kDa and 98-f 50 kDa on T. hominis protein profiles. The serum also recognised some high molecular weight antigens in the profiles of Vavraia culicis, Heterosporis anguillarum, and three species of Pleistophora but none in the remaining genera examined. It was concluded that ELISA and Western blotting could be used to detect and differentiate T. hominis in muscle biopsy tissue from patients with myositis. However, sera from T. hominis-infected patients in the terminal stages of AIDS would not be useful for detection of infections because of a sharp decline in antibody level.
months after admission to hospital of progressive HIV disease without recurrence of myositis. The microsporidia were isolated in vitro and described as a new genus and species (Hollister et al., 1996) .
In numerous genera of microsporidia, sporogony culminates in a large (more than eight) and variable number of spores packaged in an envelope of presumed parasite origin (polysporous in sporophorous vesicles 
a membrane of presumed host origin (Lom & Pekkarinen, 1999) . In Spraguea there are two sporogonic sequences which give rise to two types of spores, both lying free in host cell cytoplasm (no enveloping mem brane).
In two cases of microsporidian myositis in AIDS patients, the parasites were identified as Pleistophora spp. (Chupp et al, 1993; Grau et al, 1996) (titre -1:3,200) . Results are given as positive (+), negative (-) or borderline (+/-). ND = not done. 'Propagated in RK13 cells after isolation from human muscle (Hollister et al, 1996) . 'Propagated in larvae of Helicoverpa zea (Lepidoptera). 5 Propagated in MDCK cells after isolation from dog (Stewart et al., 1979) . 6 Wainwright isolate, propagated in MDCK cells from human nasal polyp (Hollister et al, 1993) . "Propagated in MDCK cells from human corneal biospy (Shadduck et al, 1990; Silveira & Canning, 1995) . Table I . -Microsporidia and their hosts used in ELISA and Western blotting. times the spore pellet was resuspended in MEM and stored at 4°C. ANTISERA Balb C euthymic mice were inoculated intraperitoneally (ip) or subcutaneously (sc) with 5 x 10 6 or 107 whole or disrupted spores of T. hominis with or without the adjuvant monophosphoryl lipid A plus tre halose dicorynomycolate emulsion (MPL+TDM, Sigma). Two to four inoculations were performed according to responses of individual mice. Titres were determined by ELISA using the dilution which gave an optical den sity reading equivalent to twice that of the control (normal serum) at the starting dilution. A single sample of human serum from an AIDS patient with T. hominis infection was also tested, with normal human serum as control.
ELISA
Spores of each species were added at 2 x 10 5 spores per well (4 x 10 5 spores of Encephalitozoon cuniculi, which has smaller spores) in carbonate/bicarbonate buffer overnight at 4°C. Non-adherent spores were removed with the buffer and the remainder fixed to the plate with a 1:1 mixture of ethanol and methanol. The blocking agent was 1 % horse serum (HS) in PBS. Normal mouse serum (control) and mouse antiserum to T. hominis were serially diluted in 1 % HS in PBS from 1/200 to 1/100,000 and incubated with antigen for one hour at room temperature (RT). For visualiza tion Vectastain 8 ABC-AP kits for mouse IgG (Vector Laboratories) and, in one experiment the kit for mouse IgM, were used according to the manufacturer's ins tructions and the optical densities were read 10 min and 30 min after addition of substrate in a Dynatek MR 60 Microplate reader. Controls were E. coli (strain JM109) as non-microsporidian antigen and coating buffer only in place of serum. Vectastain 1 ABC-AP kits for human IgG and, in one experiment, the kits for human IgM, IgA, IgE and kappa and lambda were used for visualising reactions of the human serum. 8 spores of E. cuni culi) were suspended in 200 pi of modified Laemmli reducing buffer (50 mM TRIS-HC1 pH 6.8, 100 mM dithriothreitol, 10 % glycerol). Spores were disrupted in a bead beater (Biospec Products), 10 % SDS was added and the sample was boiled for 5 min, spun at 1,200 g for 10 min and the supernatant containing the soluble spore proteins was collected. A 10 pi aliquot was used for determination of protein concentration (Protein Assay, BioRad). Bromophenol blue (0.1 %) was added to the remainder for SDS-PAGE in a BioRad mini-gel apparatus, using 4 % polyacrylamide stacking gel and 10 % reducing polyacrylamide separating gel. Samples were added as 10 pi aliquots containing 0.5 pg protein to the slots, as well as 5 pi of a prestained 10-250 kDa molecular weight protein standard (Amersham, Rainbow Catalogue). Gels were run in at 120 V for 5 min and at 70 V for a further 3 1 ' 2 hours. Gels were silver stained (BioRad).
SDS-PAGE

WESTERN BLOTTING
Unstained proteins separated by SDS-PAGE were trans ferred electrophoretically to Blot PVDF paper, pore size 0.2 pm (BioRad) in a Mini Trans Blot system (BioRad), for 1 h at 100 V at 5° C in running buffer (48 mM TRIS pH 9.2, 39 mM glycine, 20 % methanol). The paper with transferred proteins was dipped into methanol, incubated for 1 h in 5 % non fat dry milk powder in PBS, washed in PBS and incubated overnight with mouse or human antiserum. Reactive proteins were detected with Vectastain® ABC-AF kit (Vector Labora tories).
RESULTS
TlTRES OF MOUSE SERA U sing different combinations of inoculation route (ip or sc), whole or dismpted spores of T. homi nis, with or without MPL + TDM, it was deter mined that whole spores inoculated i.p. stimulated a good antibody response, if given with adjuvant. The titres and details of inoculation are given in Table II . Serum from mouse 485 was virtually non-reactive and was discarded.
ELISA
Antiserum 483 with a titre of 1:12,800, was used to test cross reactivity with the full range of microsporidia available. The titres are given in Table I and show that the serum was strongly reactive on T. hominis and had some cross reactivity with several of the other species tested. It was at least eight times more reactive for IgG with T. hominis antigen (1:12,800) than with V. culicis (1:800-1,600 Serum from the AIDS patient was non-reac tive on T. hominis antigens even at 1:10 dilution.
DISCUSSION
I n the present study all the microsporidia investi gated were found to have unique protein profiles. Some epitopes of immunogenic antigens were common to Trachipleistophora, Vavraia, Heterosporis and Pleistophora but none of these were shared by the remaining genera, Glugea, Loma, Spraguea and Encephalitozoon, as revealed in Western blots. There was also no reactivity with Pleistophora sp. (LS) from the shrimp L. setiferus, suggesting that this species does not belong to the genus Pleistophora and should be assi gned to another genus after morphological re-exami nation. Nilsen, 2000) was confirmed by their very similar profiles in Western blots (Fig. 2) . Unfortunately the SDS PAGE profile of Pleis tophora sp. (TB) was not sufficiently clear to support this. P. mirandellae gave an ELISA titre of 1:800, greater than that of P. typicalis (1:400) yet there was barely a reaction in the Western blot, even though the SDS PAGE profile, a duplicate of that which was blotted, revealed a good range of proteins. Furthermore Pleistophora sp. (LS) and the Encephalitozoon spp. were moderately positive by ELISA but totally nega tive in the Western blot. Some of the low titres in the ELISA could have occurred because spores were dis lodged from the plastic walls of the ELISA plates during processing. We conclude that the ELISA with serum 483 simply indicated that there was strong homologous reactivity and very little heterologous reactivity, without accurate differentiation of the other species. The Western blot results are considered to be more reliable because the amount of protein applied to the gels was adjusted to 0.5 ug for each species, making each profile comparable and because they support the phylogenetic relationships indicated by sequences of the 16S rRNA gene Nilsen, 2000) and of the RPB1 gene (Cheney et al., in press ). The 16S rDNA phylogenies showed that the species which were strongly cross reactive in the pre sent Western blot results are more closely related to one another than any of these are to Pleistophora sp. (LS) or to the genera Glugea, Loma and Spraguea. These relationships were upheld in a phylogeny based on sequences of the A-G region of the largest subunit of RNA polymerase (RPB1) (Cheney et al., in press).
SEROLOGICAL DIFFERENTITATION OF TRACHIPLEISTOPHORA Parasite, 2001, 8, 91-97 Mouse serum 443 used for Western blotting was the only seaim that had been obtained after i.p. inocula tion of spores in PBS. In other cases spores had been administered in adjuvant. Intraperitoneal inoculation has been demonstrated as a route of infection in athymic mice (Hollister et al., 1996) . It is likely that in mouse 443 there had been an active, though transient, infection and the serum would have contained anti bodies specific for internal spore antigens as well as antigens of the spore coat. This is supported by the greater number of bands revealed in Western blots by serum 443 than by the other sera. Also, as mouse serum 443 was used for Western blotting of proteins from the range of microsporidian species, while serum 483 was used in the ELISA tests against these species, the results are not strictly comparable. In spite of the differences, it is clear that T. hominis can be differen tiated from closely related microsporidia by its unique SDS-PAGE profile and that highly specific antisera raised to T. hominis could be used to screen muscle biopsies from AIDS patients with myositis to detect early infections and determine whether or not T. hominis is involved in the pathology. Such sera would also differentiate T. hominis from the other microspo ridia which have caused myositis in AIDS patients i.e. Pleistophora sp. (Ledford et al., 1985) and Brachiola vesicularum (Cali et al., 1998) . Serum from one patient, with severe myositis due to T. hominis, who was in the terminal stages of AIDS, was mildly reactive on T. hominis antigen by ELISA but non-reactive on Western blots. In a previous study of an AIDS patient with E. hellem, from whom serum samples had been kept over a period of four years, there had been a marked drop in antibody level in the terminal stages of AIDS, as revealed by Western blot ting of culture-derived spore antigens (Hollister et al., 1993) : most of the characteristic proteins of this spe cies shown by the serum samples taken earlier in the patient's illness were no longer recognised by the last sample. In the description of E. hellem which was dif ferentiated from E. cuniculi by SDS-PAGE and Wes tern blotting (Didier et al., 1991) , sera from three patients with keratoconjunctivitis due to E. hellem were tested on SDS-PAGE protein profiles of in vitro cul ture-derived spores of E. hellem.
Serum from one patient who was at a slightly earlier stage of AIDS reacted strongly against the E. hellem protein profiles, whereas the reactions of the sera of the other two patients, who were in the terminal stages of AIDS, were much weaker. Although these sera were derived from separate individuals, whose immune responses would not have been identical, the results are in accord with the decline in antibody level, which was tracked by Hollister et al. (1993) in one patient, as AIDS pro gressed. These results suggest that late stage sera might not be useful in diagnosis of microsporidial infections such as T. hominis or T. anthropophthera, as these infections are only likely to be problematic (and detected) in the terminal stages of AIDS. However, should T. hominis be detected in AIDS patients in future, retrospective examination of sera obtained at an earlier stage of AIDS might reveal high levels of spe cific antibodies. Such sera would be valuable in detec tion of T. hominis antigen in biopsies or as a control in serological surveys of patients with myositis, using the patient's sera against culture derived T. hominis antigen.
